ALVO

ALVO Biotechnology TAK Uncategorized

Alvotech higher on positive data backing biosimilar to Takeda’s Entyvio

Feb 5, 2026

alvotech-resolves-global-patent-disputes-with-regeneron-and-bayer-over-eylea-biosimilar

ALVO BAYZF Biotechnology REGN Uncategorized

Alvotech resolves global patent disputes with Regeneron and Bayer over Eylea biosimilar

Jan 29, 2026

Comments STAP Alvotech (ALVO) has reached a licensing and settlement agreement with Regeneron (REGN) and...

ALVO Biotechnology Uncategorized

Alvotech announces CEO transition

Jan 6, 2026

ALVO Biotechnology NHS Uncategorized

Alvotech announces European launch of biosimilar to Simponi

Dec 22, 2025

alvotech,-teva-reach-settlement-with-regeneron-over-eylea-biosimilar-avt06-in-us.

ALVO Biotechnology REGN TEVA Uncategorized

Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S.

Dec 19, 2025

Luis Alvarez Alvotech (ALVO) and Teva Pharmaceuticals (TEVA) have reached a settlement and license agreement...

alvotech-to-raise-$100m-via-convertible-bonds,-provides-2026-forecast

ALVO Biotechnology Uncategorized

Alvotech to raise $100M via convertible bonds, provides 2026 forecast

Dec 17, 2025

Alvotech (ALVO) launched a $100 million offering of senior unsecured convertible notes due 2030 and...